https://www.selleckchem.com/pr....oducts/tiplaxtinin-p
fluence their use, such as ease of use and resourcing. To date, the G8 and VES-13 have the most evidence to recommend their use to inform the need for geriatric assessment. When choosing a screening tool, clinicians will need to weigh the tradeoffs between sensitivity and specificity. Future research needs to further validate or improve current screening tools and explore other factors that can influence their use, such as ease of use and resourcing.Older multi-morbid persons often fall seriously ill due to COVID-19. To be a
Like
Comment
Share
